Nyxoah SA
ISIN: BE0974358906 | Ticker: NYXH | LEI: 5493002O1ESKZ18OXR80
Country: Belgium
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA).
Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, patient-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the world’s most common sleep disordered breathing condition that is associated with increased mortality risk* and comorbidities including cardiovascular diseases, depression and stroke.
2009
Served areaWorldwide
HeadquartersRue Edouard Belin 12, 1435 Mont-Saint-Guibert – Belgium
| Line item in (eur) | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 |
|---|---|---|---|---|
| Assets | N/A | 114,080,000.00 | N/A | 170,830,000.00 |
| Noncurrent Assets | N/A | 19,972,000.00 | N/A | 30,770,000.00 |
| Property Plant And Equipment | N/A | 713,000.00 | N/A | 2,020,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 15,853,000.00 | N/A | 25,322,000.00 |
| Noncurrent Receivables | N/A | 91,000.00 | N/A | 164,000.00 |
| Deferred Tax Assets | N/A | 32,000.00 | N/A | 46,000.00 |
| Current Assets | N/A | 94,108,000.00 | N/A | 140,060,000.00 |
| Inventories | N/A | 55,000.00 | N/A | 346,000.00 |
| Current Trade Receivables | N/A | 0.00 | N/A | 226,000.00 |
| Cash and cash equivalents | 5,855,000.00 | 92,300,000.00 | 92,300,000.00 | 135,509,000.00 |
| Other Current Assets | N/A | 109,000.00 | N/A | 1,693,000.00 |
| Equity And Liabilities | N/A | 114,080,000.00 | N/A | 170,830,000.00 |
| Equity | N/A | 97,190,000.00 | N/A | 148,622,000.00 |
| Issued Capital | N/A | 3,796,000.00 | N/A | 4,427,000.00 |
| Retained Earnings | N/A | -60,341,000.00 | N/A | -87,167,000.00 |
| Share Premium | N/A | 150,936,000.00 | N/A | 228,033,000.00 |
| Reserve Of Sharebased Payments | N/A | 2,650,000.00 | N/A | 3,127,000.00 |
| Liabilities | N/A | 16,890,000.00 | N/A | 22,208,000.00 |
| Noncurrent Liabilities | N/A | 10,488,000.00 | N/A | 10,636,000.00 |
| Noncurrent Provisions | N/A | 0.00 | N/A | 12,000.00 |
| Deferred Tax Liabilities | N/A | 0.00 | N/A | 5,000.00 |
| Other Noncurrent Financial Liabilities | N/A | 7,607,000.00 | N/A | 7,802,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | 37,000.00 | N/A | 80,000.00 |
| Current Liabilities | N/A | 6,402,000.00 | N/A | 11,572,000.00 |
| Other Current Payables | N/A | 4,123,000.00 | N/A | 3,633,000.00 |
| Current Tax Liabilities Current | N/A | 0.00 | N/A | 2,808,000.00 |
| Other Current Financial Liabilities | N/A | 616,000.00 | N/A | 554,000.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
|---|---|---|
| Revenue From Sale Of Goods | 69,000.00 | 852,000.00 |
| Profit Loss From Operating Activities | -11,224,000.00 | -26,242,000.00 |
| Finance Income | 62,000.00 | 3,675,000.00 |
| Finance Costs | 990,000.00 | 2,072,000.00 |
| Profit Loss Before Tax | -12,152,000.00 | -24,639,000.00 |
| Income Tax Expense Continuing Operations | 93,000.00 | 2,980,000.00 |
| Profit (loss) | -12,245,000.00 | -27,619,000.00 |
| Profit Loss Attributable To Owners Of Parent | -12,245,000.00 | -27,619,000.00 |
| Line item in (eur) | 01.01.2021 | 02.01.2020 | 01.01.2022 | 02.01.2021 |
|---|---|---|---|---|
| Profit (loss) | -12,245,000.00 | N/A | -27,619,000.00 | N/A |
| Adjustments For Finance Costs | 990,000.00 | N/A | 2,072,000.00 | N/A |
| Adjustments For Decrease Increase In Inventories | 55,000.00 | N/A | 291,000.00 | N/A |
| Adjustments For Increase Decrease In Trade Account Payable | -1,109,000.00 | N/A | -1,670,000.00 | N/A |
| Adjustments For Provisions | 7,000.00 | N/A | -13,000.00 | N/A |
| Adjustments For Sharebased Payments | 2,549,000.00 | N/A | 1,270,000.00 | N/A |
| Other Adjustments For Noncash Items | -134,000.00 | N/A | -595,000.00 | N/A |
| Cash Flows From Used In Operations | -6,864,000.00 | N/A | -25,336,000.00 | N/A |
| Interest Received Classified As Operating Activities | 3,000.00 | N/A | 0.00 | N/A |
| Income Taxes Paid Refund Classified As Operating Activities | 104,000.00 | N/A | 274,000.00 | N/A |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 562,000.00 | N/A | 1,469,000.00 | N/A |
| Purchase Of Intangible Assets Classified As Investing Activities | 10,118,000.00 | N/A | 10,348,000.00 | N/A |
| Cash Flows From Used In Investing Activities | -10,693,000.00 | N/A | -11,817,000.00 | N/A |
| Proceeds From Issuing Shares | 103,583,000.00 | N/A | 77,728,000.00 | N/A |
| Proceeds From Borrowings Classified As Financing Activities | 1,000,000.00 | N/A | 0.00 | N/A |
| Repayments Of Borrowings Classified As Financing Activities | 63,000.00 | N/A | 83,000.00 | N/A |
| Payments Of Lease Liabilities Classified As Financing Activities | 479,000.00 | N/A | 500,000.00 | N/A |
| Interest Paid Classified As Financing Activities | 151,000.00 | N/A | 385,000.00 | N/A |
| Other Inflows Outflows Of Cash Classified As Financing Activities | 0.00 | N/A | -8,000.00 | N/A |
| Cash Flows From Used In Financing Activities | 104,025,000.00 | N/A | 76,472,000.00 | N/A |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 86,468,000.00 | N/A | 39,319,000.00 | N/A |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -23,000.00 | N/A | 3,890,000.00 | N/A |
| Cash and cash equivalents | 92,300,000.00 | 5,855,000.00 | 135,509,000.00 | 92,300,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 18.08.23 | Moreau Loïc | Executive member | Buy | EUR 48,416.52 |
| 14.08.23 | Moreau Loïc | Executive member | Buy | EUR 28,697.60 |
| 11.08.23 | Moreau Loïc | Executive member | Buy | EUR 21,957.60 |
| 04.07.23 | Wildman Ventures LLC | Board | Buy | EUR 0.00 |
| 02.07.23 | Gianello Pierre | Board | Buy | EUR 0.00 |
| 01.07.23 | Rakin Kevin | Board | Buy | EUR 0.00 |
| 17.05.23 | Khalag Hares | Executive member | Buy | EUR 0.00 |
| 16.04.23 | Subbaroyan Jeyakumar | Executive member | Buy | EUR 0.00 |
| 14.04.23 | Taelman Olivier | Executive member | Buy | EUR 0.00 |
| 13.04.23 | Vanwittenbergh Inge | Executive member | Buy | EUR 0.00 |
BE0974358906
LEI5493002O1ESKZ18OXR80
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.